Annual Revenue
$1000.00
-$59.00 K-98.33%
31 December 2023
Summary:
Titan Pharmaceuticals annual revenue is currently $1000.00, with the most recent change of -$59.00 thousand (-98.33%) on 31 December 2023. During the last 3 years, it has fallen by -$248.00 thousand (-99.60%). TTNP annual revenue is now -99.99% below its all-time high of $17.50 million, reached on 31 December 1997.TTNP Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 June 2024
Summary:
Titan Pharmaceuticals quarterly revenue is not available.TTNP Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 June 2024
Summary:
Titan Pharmaceuticals TTM revenue is not available.TTNP TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -99.6% | - | - |
| 5 y5 years | -99.7% | - | - |
TTNP Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.6% | at low | ||||
| 5 y | 5 years | -99.8% | at low | ||||
| alltime | all time | -100.0% | at low |
Titan Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $1000.00(-98.3%) | - | - |
| June 2023 | - | $1000.00(-98.0%) | $56.00 K(-8.2%) |
| Dec 2022 | $60.00 K(-75.9%) | $51.00 K(+1175.0%) | $61.00 K(+335.7%) |
| Sept 2022 | - | $4000.00(+33.3%) | $14.00 K(-72.0%) |
| June 2022 | - | $3000.00(0.0%) | $50.00 K(-64.0%) |
| Mar 2022 | - | $3000.00(-25.0%) | $139.00 K(-44.2%) |
| Dec 2021 | $249.00 K(-53.8%) | $4000.00(-90.0%) | $249.00 K(-66.3%) |
| Sept 2021 | - | $40.00 K(-56.5%) | $739.00 K(+5.7%) |
| June 2021 | - | $92.00 K(-18.6%) | $699.00 K(+7.2%) |
| Mar 2021 | - | $113.00 K(-77.1%) | $652.00 K(+21.0%) |
| Dec 2020 | $539.00 K(+71.1%) | $494.00 K(+997.8%) | $539.00 K(-193.9%) |
| June 2020 | - | $45.00 K(-105.6%) | -$574.00 K(-282.2%) |
| Dec 2019 | $315.00 K(-94.7%) | -$809.00 K(-525.8%) | $315.00 K(-81.0%) |
| Sept 2019 | - | $190.00 K(-37.5%) | $1.65 M(-46.9%) |
| June 2019 | - | $304.00 K(-51.7%) | $3.11 M(-43.2%) |
| Mar 2019 | - | $630.00 K(+18.9%) | $5.48 M(-7.3%) |
| Dec 2018 | $5.91 M(+2649.3%) | $530.00 K(-67.9%) | $5.91 M(+8.7%) |
| Sept 2018 | - | $1.65 M(-38.2%) | $5.44 M(+42.0%) |
| June 2018 | - | $2.67 M(+150.8%) | $3.83 M(+209.1%) |
| Mar 2018 | - | $1.06 M(+1734.5%) | $1.24 M(+476.3%) |
| Dec 2017 | $215.00 K(-98.6%) | $58.00 K(+45.0%) | $215.00 K(+12.0%) |
| Sept 2017 | - | $40.00 K(-48.1%) | $192.00 K(+7.9%) |
| June 2017 | - | $77.00 K(+92.5%) | $178.00 K(-98.8%) |
| Mar 2017 | - | $40.00 K(+14.3%) | $15.11 M(+0.3%) |
| Dec 2016 | $15.06 M(+801.6%) | $35.00 K(+34.6%) | $15.06 M(+0.2%) |
| Sept 2016 | - | $26.00 K(-99.8%) | $15.03 M(+0.2%) |
| June 2016 | - | $15.00 M(+1874.2%) | $15.00 M(+329.4%) |
| Dec 2015 | $1.67 M(-54.2%) | - | - |
| June 2015 | - | $760.00 K(-16.6%) | $3.49 M(-4.1%) |
| Mar 2015 | - | $911.00 K(-0.1%) | $3.65 M(0.0%) |
| Dec 2014 | $3.65 M(-65.2%) | $912.00 K(+0.1%) | $3.65 M(+0.0%) |
| Sept 2014 | - | $911.00 K(0.0%) | $3.64 M(-26.1%) |
| June 2014 | - | $911.00 K(0.0%) | $4.93 M(-20.7%) |
| Mar 2014 | - | $911.00 K(0.0%) | $6.22 M(-40.7%) |
| Dec 2013 | $10.48 M(+47.3%) | $911.00 K(-58.6%) | $10.48 M(-18.3%) |
| Sept 2013 | - | $2.20 M(0.0%) | $12.83 M(+8.2%) |
| June 2013 | - | $2.20 M(-57.5%) | $11.86 M(+7.6%) |
| Mar 2013 | - | $5.17 M(+58.8%) | $11.02 M(+54.9%) |
| Dec 2012 | $7.12 M(+75.0%) | $3.26 M(+165.4%) | $7.12 M(+35.0%) |
| Sept 2012 | - | $1.23 M(-9.7%) | $5.27 M(+4.3%) |
| June 2012 | - | $1.36 M(+7.1%) | $5.05 M(+15.1%) |
| Mar 2012 | - | $1.27 M(-10.1%) | $4.39 M(+7.9%) |
| Dec 2011 | $4.07 M(-59.7%) | $1.41 M(+39.6%) | $4.07 M(-24.4%) |
| Sept 2011 | - | $1.01 M(+45.6%) | $5.38 M(-32.5%) |
| June 2011 | - | $695.00 K(-26.7%) | $7.97 M(-7.5%) |
| Mar 2011 | - | $948.00 K(-65.2%) | $8.62 M(-14.6%) |
| Dec 2010 | $10.09 M(>+9900.0%) | $2.73 M(-24.3%) | $10.09 M(+36.5%) |
| Sept 2010 | - | $3.60 M(+168.3%) | $7.39 M(+94.9%) |
| June 2010 | - | $1.34 M(-44.7%) | $3.79 M(+52.9%) |
| Mar 2010 | - | $2.42 M(+8881.5%) | $2.48 M(+3040.5%) |
| Dec 2009 | $79.00 K | $27.00 K(-6.9%) | $79.00 K(+51.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | $29.00 K(+26.1%) | $52.00 K(+48.6%) |
| Mar 2009 | - | $23.00 K(+91.7%) | $35.00 K(-58.8%) |
| June 2008 | - | $12.00 K(-80.3%) | $85.00 K(0.0%) |
| Mar 2008 | - | $61.00 K(+408.3%) | $85.00 K(+254.2%) |
| Dec 2007 | $24.00 K(-25.0%) | $12.00 K(0.0%) | $24.00 K(-42.9%) |
| June 2007 | - | $12.00 K(-58.6%) | $42.00 K(+31.3%) |
| Dec 2006 | $32.00 K(-64.0%) | $29.00 K(+2800.0%) | $32.00 K(-50.0%) |
| Sept 2006 | - | $1000.00(0.0%) | $64.00 K(0.0%) |
| June 2006 | - | $1000.00(0.0%) | $64.00 K(-15.8%) |
| Mar 2006 | - | $1000.00(-98.4%) | $76.00 K(-14.6%) |
| Dec 2005 | $89.00 K(+187.1%) | $61.00 K(+6000.0%) | $89.00 K(+53.4%) |
| Sept 2005 | - | $1000.00(-92.3%) | $58.00 K(+1.8%) |
| June 2005 | - | $13.00 K(-7.1%) | $57.00 K(+29.5%) |
| Mar 2005 | - | $14.00 K(-53.3%) | $44.00 K(+41.9%) |
| Dec 2004 | $31.00 K(-65.2%) | $30.00 K(+2900.0%) | $31.00 K(-51.6%) |
| Mar 2004 | - | $1000.00(-98.4%) | $64.00 K(-28.1%) |
| Dec 2003 | $89.00 K(-96.9%) | $61.00 K(+2950.0%) | $89.00 K(-78.9%) |
| June 2003 | - | $2000.00(-92.3%) | $422.00 K(-26.1%) |
| Mar 2003 | - | $26.00 K(-89.0%) | $571.00 K(-80.3%) |
| Dec 2002 | $2.89 M(-36.7%) | $236.00 K(+49.4%) | $2.89 M(-10.9%) |
| Sept 2002 | - | $158.00 K(+4.6%) | $3.25 M(-10.3%) |
| June 2002 | - | $151.00 K(-93.6%) | $3.62 M(-42.9%) |
| Mar 2002 | - | $2.35 M(+298.5%) | $6.34 M(+38.6%) |
| Dec 2001 | $4.57 M(+143.2%) | $589.00 K(+11.1%) | $4.57 M(+0.4%) |
| Sept 2001 | - | $530.00 K(-81.6%) | $4.55 M(-3.5%) |
| June 2001 | - | $2.87 M(+395.3%) | $4.72 M(+122.0%) |
| Mar 2001 | - | $580.00 K(+1.9%) | $2.13 M(+13.0%) |
| Dec 2000 | $1.88 M(+526.7%) | $569.00 K(-18.1%) | $1.88 M(+24.4%) |
| Sept 2000 | - | $695.00 K(+147.3%) | $1.51 M(+65.0%) |
| June 2000 | - | $281.00 K(-16.1%) | $916.00 K(+44.0%) |
| Mar 2000 | - | $335.00 K(+67.5%) | $636.00 K(+82.8%) |
| Dec 1999 | $300.00 K(>+9900.0%) | $200.00 K(+100.0%) | $348.00 K(+610.2%) |
| Sept 1999 | - | $100.00 K(+9900.0%) | $49.00 K(0.0%) |
| June 1999 | - | $1000.00(-97.9%) | $49.00 K(-66.9%) |
| Mar 1999 | - | $47.00 K(-147.5%) | $148.00 K(-26.4%) |
| Dec 1998 | $1000.00(-100.0%) | -$99.00 K(-199.0%) | $201.00 K(-98.9%) |
| Sept 1998 | - | $100.00 K(0.0%) | $17.70 M(0.0%) |
| June 1998 | - | $100.00 K(0.0%) | $17.70 M(0.0%) |
| Mar 1998 | - | $100.00 K(-99.4%) | $17.70 M(0.0%) |
| Dec 1997 | $17.50 M(+5733.3%) | $17.40 M(>+9900.0%) | $17.70 M(+3440.0%) |
| Sept 1997 | - | $100.00 K(0.0%) | $500.00 K(0.0%) |
| June 1997 | - | $100.00 K(0.0%) | $500.00 K(0.0%) |
| Mar 1997 | - | $100.00 K(-50.0%) | $500.00 K(0.0%) |
| Dec 1996 | $300.00 K(+200.0%) | $200.00 K(+100.0%) | $500.00 K(+66.7%) |
| Sept 1996 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| June 1996 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Mar 1996 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
| Dec 1995 | $100.00 K | - | - |
| Sept 1995 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| June 1995 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1995 | - | $100.00 K | $100.00 K |
FAQ
- What is Titan Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Titan Pharmaceuticals?
- What is the all time high quarterly revenue for Titan Pharmaceuticals?
- What is the all time high TTM revenue for Titan Pharmaceuticals?
What is Titan Pharmaceuticals annual revenue?
The current annual revenue of TTNP is $1000.00
What is the all time high annual revenue for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual revenue is $17.50 M
What is the all time high quarterly revenue for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly revenue is $17.40 M
What is the all time high TTM revenue for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high TTM revenue is $17.70 M